Product and process innovation in biopharmaceuticals: a new perspective on development

被引：53

作者：

Lim, LPL ^{[1
]}

Garnsey, E ^{[1
]}

Gregory, M ^{[1
]}

机构：

[1] Univ Cambridge, Inst Mfg, Cambridge, England

来源：

R & D MANAGEMENT | 2006年 / 36卷 / 01期

基金：

英国工程与自然科学研究理事会; 英国经济与社会研究理事会;

关键词：

D O I：

10.1111/j.1467-9310.2006.00413.x

中图分类号：

F [经济];

学科分类号：

02 ;

摘要：

Developing new products and processes is increasingly a focal point of competition and often requires the development and successful implementation of novel process technologies. The process development and production of a new biological entity are significantly more complex than those for small molecule drugs. Conventional new product development models in the literature on firm level innovation fail to explain the nature of development projects for biopharmaceuticals. This paper makes the case that a new perspective is required to understand the management of product and process development in biopharmaceuticals. An explanatory model is proposed for this purpose.

引用

页码：27 / 36

页数：10

共 31 条

[1] ABERNATHY WJ, 1978, TECHNOL REV, V80, P2
[2] Allen D., 1993, DEVELOPING SUCCESSFU
[3] [Anonymous], PUBLIC PRIVATE SECTO
[4] [Anonymous], 2004, PHARM CGMP 21 CENT R
[5] BERGERON MY, 2001, INT J BIOTECHNOLOGY, V3, P362
[6] BROWN SL, 1995, ACAD MANAGE REV, V20, P2
[7] CLARK KB, 1990, HARVARD BUS REV, V68, P107
[8] COCKBURN I, 1999, STUDIES COMPETITIVE
[9] PERSPECTIVE - 3RD-GENERATION NEW PRODUCT PROCESSES
COOPER, RG
[J]. JOURNAL OF PRODUCT INNOVATION MANAGEMENT, 1994, 11 (01) : 3 - 14
[10] NEW PRODUCT SUCCESS IN INDUSTRIAL FIRMS
COOPER, RG
[J]. INDUSTRIAL MARKETING MANAGEMENT, 1982, 11 (03) : 215 - 223

← 1 2 3 4 →